Perfil
Noam Frey currently works at Summit Therapeutics, Inc., as Senior VP-Global Medical Affairs from 2023.
Dr. Frey also formerly worked at InterMune, Inc., as Vice President-Medical Affairs from 2013 to 2015 and Amryt Pharma Holdings Ltd., as Vice President-Medical Affairs from 2022 to 2023.
Dr. Frey received his Masters Business Admin degree from the University of Washington and doctorate degree from Tel-Aviv University.
Cargos activos de Noam Frey
| Empresas | Cargo | Inicio |
|---|---|---|
| SUMMIT THERAPEUTICS INC. | Corporate Officer/Principal | 01/09/2023 |
Antiguos cargos conocidos de Noam Frey.
| Empresas | Cargo | Fin |
|---|---|---|
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Director Técnico/Científico/I+D | 01/04/2023 |
| INTERMUNE INC | Director Técnico/Científico/I+D | 01/02/2015 |
Formación de Noam Frey.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
InterMune, Inc.
InterMune, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
University of Washington
University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tel-Aviv University
Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for patients with rare and orphan diseases | Health Technology |
Summit Therapeutics, Inc.
Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
- Bolsa de valores
- Insiders
- Noam Frey
















